Vitamin E in Human Health and Disease

REFERENCES

• H M Evans, and K S Bishop. (1922). On the existence of a hitherto unrecognised dietary factor essential for reproduction. Science 56:650–651.
   PubMedGoogle Scholar
• J E Maras, O I Bermudez, N Qiao, P J Bakun, E L Boody-Alter, and K L Tucker. (2004). Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc 104:567–575.
   PubMed Web of Science ®Google Scholar
• DCK Roberts. Vitamin E. Sydney: Australian Professional Publications, (1990).
   Google Scholar
• WA Pryor. Vitamin E and Carotenoids: Abstracts. Lagrange, IL: Veris, (1996).
   Google Scholar
• I S Young, and J V Woodside. (2001). Antioxidants in health and disease. J Clin Pathol 54:176–186.
   PubMed Web of Science ®Google Scholar
• A Azzi, R Gysin, P Kempna, A Munteanu, L Villacorta, T Visarius, and J M Zingg. (2004). Regulation of gene expression by alpha-tocopherol. Biol Chem 385:585–591.
   PubMed Web of Science ®Google Scholar
• J J Biemer. (1980). Acanthocytosis—biochemical and physiological considerations. Ann Clin Lab Sci 10:238–249.
   Google Scholar
• J M Aparicio, A Belanger-Quintana, L Suarez, D Mayo, J Benitez, M Diaz, and H Escobar. (2001). Ataxia with isolated vitamin E deficiency: case report and review of the literature. J Pediatr Gastroenterol Nutr 33:206–210.
   Google Scholar
• A Tasinato, D Boscoboinik, G Bartoli, P Maroni, and A Azzi. (1995). d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA 92:12190–12194.
   PubMed Web of Science ®Google Scholar
• J F KeaneyJr, Y Guo, D Cunningham, G T Shwaery, A Xu, and J A Vita. (1996). Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 98:386–394.
   PubMedGoogle Scholar
• J E Freedman, J H Farhat, J Loscalzo, and J F KeaneyJr. (1996). α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94:2434–2440.
   PubMed Web of Science ®Google Scholar
• S Devaraj, D Li, and I Jialal. (1996). The effects of α −tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin-1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 98:756–763.
   PubMed Web of Science ®Google Scholar
• S Devaraj, and I Jialal. (1998). The effects of α-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 9:11–15.
   PubMed Web of Science ®Google Scholar
• S R Thomas, and R Stocker. (2000). Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. Free Radic Biol Med 28:1795–1805.
   PubMed Web of Science ®Google Scholar
• D Steinberg. (2000). Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?. Curr Opin Lipidol 11:603–607.
   PubMed Web of Science ®Google Scholar
• J G Bieri, L Corash, and V S Hubbard. (1983). Medical uses of vitamin E. N Engl J Med 308:1063–1071.
   PubMed Web of Science ®Google Scholar
• R B Weinberg, B S VanderWerken, R A Anderson, J E Stegner, and M J Thomas. (2001). Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol 21:1029–1033.
   PubMed Web of Science ®Google Scholar
• M K Horwitt. (2001). Critique of the requirement for vitamin E. Am J Clin Nutr 73:1003–1005.
   PubMed Web of Science ®Google Scholar
• M Traber. (2001). Vitamin E: too much or not enough?. Am J Clin Nutr 73:997–998.
   Google Scholar
• J G Bieri. (2002). Comments on the new dietary reference intake for vitamin E. Am J Clin Nutr 75:781. discussion 781-782
   Google Scholar
• Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Food and Nutrition Board: Institute of Medicine. Pp 186–283. Washington, DC: National Academy Press, (2000).
   Google Scholar
• E R Miller3rd, R Pastor-Barriuso, D Dalal, R A Riemersma, L J Appel, and E Guallar. (2005). Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46.
   PubMed Web of Science ®Google Scholar
• E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, J M Arnold, C Ross, A Arnold, P Sleight, J Probstfield, and G R Dagenais. (2005). Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347.
   PubMed Web of Science ®Google Scholar
• R Marchioli, G Levantesi, A Macchia, R M Marfisi, G L Nicolosi, L Tavazzi, G Tognoni, and F Valagussa. (2006). Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) 7:347–350.
   PubMedGoogle Scholar
• H J Kayden, and M G Traber. (1993). Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343–358.
   PubMed Web of Science ®Google Scholar
• J Bunyan, D McHale, J Green, and S Marcinkiewicz. (1961). Biological potencies of ε- and ζ1-tocopherol and 5-methyltocol. Br J Nutri 15:253–257.
   PubMed Web of Science ®Google Scholar
• D H Blatt, S W Leonard, and M G Traber. (2001). Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 17:799–805.
   PubMed Web of Science ®Google Scholar
• H J Kayden, and T Wisniewski. (2000). On the biological activity of vitamin E. Am J Clin Nutr 72:201–202.
   Google Scholar
• M G Traber, I Goldberg, E Davidson, N Lagmay, and H J Kayden. (1990). Vitamin E uptake by human intestinal cells during lipolysis in vitro. Gastroenterology 98:96–103.
   PubMedGoogle Scholar
• E Reboul, A Klein, F Bietrix, B Gleize, C Malezet-Desmoulins, M Schneider, A Margotat, L Lagrost, X Collet, and P Borel. (2006). Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem 281:4739–4745.
   PubMed Web of Science ®Google Scholar
• M G Traber, T Olivecrona, and H J Kayden. (1985). Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J Clin Invest 75:1729–1734.
   PubMed Web of Science ®Google Scholar
• Q Jiang, S Christen, M K Shigenaga, and B N Ames. (2001). γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74:714–722.
   PubMed Web of Science ®Google Scholar
• M G Traber, and H J Kayden. (1989). Preferential incorporation of α-tocopherol vs γ-tocopherol in human lipoproteins. Am J Clin Nutr 49:517–526.
   PubMed Web of Science ®Google Scholar
• M G Traber, G W Burton, L Hughes, K U Ingold, H Hidaka, M Malloy, J Kane, J Hyams, and H J Kayden. (1992). Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J Lipid Res 33:1171–1182.
   PubMed Web of Science ®Google Scholar
• M W Clarke, A J Hooper, H A Headlam, J HY Wu, K D Croft, and J R Burnett. (2006). Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia. Clin Chem 52:1339–1345.
   Google Scholar
• K Minehira-Castelli, S W Leonard, Q M Walker, M G Traber, and S G Young. (2006). Absence of VLDL secretion does not affect alpha-tocopherol content in peripheral tissues. J Lipid Res 47:1733–1738.
   PubMed Web of Science ®Google Scholar
• J F Oram, A M Vaughan, and R Stocker. (2001). ATP-binding cassette transporter A1 mediates cellular secretion of α-tocopherol. J Biol Chem 276:39898–39902.
   PubMed Web of Science ®Google Scholar
• D J Murphy, and R D Mavis. (1981). Membrane transfer of α-tocopherol. Influence of soluble α-tocopherol-binding factors from the liver, lung, heart, and brain of the rat. J Biol Chem 256:10464–10468.
   PubMed Web of Science ®Google Scholar
• K U Ingold, G W Burton, D O Foster, L Hughes, D A Lindsay, and A Webb. (1987). Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 22:163–172.
   PubMed Web of Science ®Google Scholar
• M G Traber, G W Burton, K U Ingold, and H J Kayden. (1990). RRR- and SRR-α-tocopherols are secreted without discrimination in human chylomicrons, but RRR-α-tocopherol is preferentially secreted in very low density lipoproteins. J Lipid Res 31:675–685.
   PubMed Web of Science ®Google Scholar
• A Hosomi, M Arita, Y Sato, C Kiyose, T Ueda, O Igarashi, H Arai, and K Inoue. (1997). Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105–108.
   PubMed Web of Science ®Google Scholar
• M Arita, K Nomura, H Arai, and K Inoue. (1997). Alpha-tocopherol transfer protein stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc Natl Acad Sci USA 94:12437–12441.
   PubMed Web of Science ®Google Scholar
• J Qian, S Morley, K Wilson, P Nava, J Atkinson, and D Manor. (2005). Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res 46:2072–2082.
   PubMed Web of Science ®Google Scholar
• S Zimmer, A Stocker, M N Sarbolouki, S E Spycher, J Sassoon, and A Azzi. (2000). A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem 275:25672–25680.
   PubMed Web of Science ®Google Scholar
• P Kempna, J Zingg, R Ricciarelli, M Hierl, S Saxena, and A Azzi. (2003). Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic Biol Med 34:1458–1472.
   Google Scholar
• N Shibata, K-i Jishage, M Arita, M Watanabe, Y Kawase, K Nishikawa, Y Natori, H Inoue, H Shimano, N Yamada, M Tsujimoto, and H Arai. (2006). Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J 20:2642–2644.
   Google Scholar
• A K Dutta-Roy, M J Gordon, D J Leishman, B J Paterson, G G Duthie, and W P James. (1993). Purification and partial characterisation of an α-tocopherol-binding protein from rabbit heart cytosol. Mol Cell Biochem 123:139–144.
   Google Scholar
• U Burck, H H Goebel, H D Kuhlendahl, C Meier, and K M Goebel. (1981). Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 12:267–278.
   PubMed Web of Science ®Google Scholar
• L Cavalier, K Ouahchi, H J Kayden, S Di Donato, L Reutenauer, J L Mandel, and M Koenig. (1998). Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 62:301–310.
   PubMed Web of Science ®Google Scholar
• M Koenig, and J L Mandel. (1997). Deciphering the cause of Friedreich ataxia. Curr Opin Neurobiol 7:689–694.
   PubMed Web of Science ®Google Scholar
• M C Tanyel, and L D Mancano. (1997). Neurologic findings in vitamin E deficiency. Am Fam Physician 55:197–201.
   PubMed Web of Science ®Google Scholar
• T Yokota, K Igarashi, T Uchihara, K Jishage, H Tomita, A Inaba, Y Li, M Arita, H Suzuki, H Mizusawa, and H Arai. (2001). Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci USA 98:15185–15190.
   PubMed Web of Science ®Google Scholar
• Y Terasawa, Z Ladha, S W Leonard, J D Morrow, D Newland, D Sanan, L Packer, M G Traber, and R V FareseJr. (2000). Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 97:13830–13834.
   PubMed Web of Science ®Google Scholar
• R Mashima, P K Witting, and R Stocker. (2001). Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 12:411–418.
   PubMed Web of Science ®Google Scholar
• D Pratico, R K Tangirala, D J Rader, J Rokach, and G A Fitz Gerald. (1998). Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4:1189–1192.
   PubMed Web of Science ®Google Scholar
• S R Thomas, S B Leichtweis, K Pettersson, K D Croft, T A Mori, A J Brown, and R Stocker. (2001). Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21:585–593.
   PubMed Web of Science ®Google Scholar
• A Shaish, J George, B Gilburd, P Keren, H Levkovitz, and D Harats. (1999). Dietary beta-carotene and α-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model. Arterioscler Thromb Vasc Biol 19:1470–1475.
   PubMed Web of Science ®Google Scholar
• R Ross. (1999). Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126.
   PubMed Web of Science ®Google Scholar
• D Steinburg, S Paramathypathy, E C Thomas, J C Khoo, and J L Witztum. (1989). Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–923.
   PubMed Web of Science ®Google Scholar
• J Neuzil, C Weber, and A Kontush. (2001). The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157:257–283.
   PubMed Web of Science ®Google Scholar
• B Halliwell. (2000). The antioxidant paradox. Lancet 355:1179–1180.
   PubMed Web of Science ®Google Scholar
• I Jialal, M Traber, and S Devaraj. (2001). Is there a vitamin E paradox?. Curr Opin Lipidol 12:49–53.
   Google Scholar
• H Esterbauer, M Dieber-Rotheneder, G Striegl, and G Waeg. (1991). Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53:314S–321S.
   PubMed Web of Science ®Google Scholar
• B Frei, M Kim, and B Ames. (1990). Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 87:4879–4883.
   PubMed Web of Science ®Google Scholar
• R Stocker, V Bowry, and B Frei. (1991). Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 88:1646–1650.
   PubMed Web of Science ®Google Scholar
• K Ingold, V Bowry, R Stocker, and C Walling. (1993). Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: Unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci USA 90:45–49.
   PubMed Web of Science ®Google Scholar
• S R Thomas, J Neuzil, and R Stocker. (1996). Cosupplementation with coenzyme Q prevents the prooxidant effect of α-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol 16:687–696.
   PubMed Web of Science ®Google Scholar
• J M Upston, A C Terentis, and R Stocker. (1999). Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 13:977–994.
   PubMed Web of Science ®Google Scholar
• J Neuzil, P K Witting, and R Stocker. (1997). α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids. Proc Natl Acad Sci USA 94:7885–7890.
   PubMed Web of Science ®Google Scholar
• J H Brasen, K Koenig, H Bach, A Kontush, H Heinle, P K Witting, S Yla-Herttuala, R Stocker, and U Beisiegel. (2002). Comparison of the effects of α-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. Atherosclerosis 163:249–259.
   PubMed Web of Science ®Google Scholar
• A C Terentis, S R Thomas, J A Burr, D C Liebler, and R Stocker. (2002). Vitamin E oxidation in human atherosclerotic lesions. Circ Res 90:333–339.
   PubMed Web of Science ®Google Scholar
• X Niu, V Zammit, J M Upston, R T Dean, and R Stocker. (1999). Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 19:1708–1718.
   PubMed Web of Science ®Google Scholar
• C Suarna, B J Wu, K Choy, T Mori, K Croft, O Cynshi, and R Stocker. (2006). Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic Biol Med 41:722–730.
   Google Scholar
• E A Meagher, O P Barry, J A Lawson, J Rokach, and G A Fitz Gerald. (2001). Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285:1178–1182.
   PubMed Web of Science ®Google Scholar
• S Devaraj, R Tang, B Adams-Huet, A Harris, T Seenivasan, J A de Lemos, and I Jialal. (2007). Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 86:1302–1398.
   Google Scholar
• L Roberts, J Oates, M Linton, S Fazio, B Meador, M Gross, Y Shyr, and J Morrow. (2007). The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 43:1388–1393.
   PubMed Web of Science ®Google Scholar
• R Rodrigo, H Prat, W Passalacqua, J Araya, and J P Bachler. (2008). Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond) 114:625–634.
   PubMed Web of Science ®Google Scholar
• E B Rimm, M J Stampfer, A Ascherio, E Giovannucci, G A Colditz, and W C Willett. (1993). Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450–1456.
   PubMed Web of Science ®Google Scholar
• M J Stampfer, C H Hennekens, J E Manson, G A Colditz, B Rosner, and W C Willett. (1993). Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444–1449.
   PubMed Web of Science ®Google Scholar
• F Galli, R Lee, C Dunster, and F J Kelly. (2002). Gas chromatography mass spectrometry analysis of carboxyethyl-hydroxychroman metabolites of α- and γ-tocopherol in human plasma. Free Radic Biol Med 32:333–340.
   PubMedGoogle Scholar
• E J Simon, A Eisengart, W Sundheim, and A T Milhoart. (1956). The metabolism of vitamin E. II. Purification characterisation of urinary metabolites of α −tocopherol. J Biol Chem 221:807–817.
   PubMed Web of Science ®Google Scholar
• M Schultz, M Leist, M Petrzika, B Gassmann, and R Brigelius-Flohe. (1995). Novel urinary metabolite of α-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?. Am J Clin Nutr 621 (6 Suppl):1527S–1534S.
   Google Scholar
• M G Traber, D Rader, R V Acuff, R Ramakrishnan, H B Brewer, and H J Kayden. (1998). Vitamin E dose-response studies in humans with use of deuterated RRR-α-tocopherol. Am J Clin Nutr 68:847–853.
   PubMed Web of Science ®Google Scholar
• R Lee, and F J Kelly. (1999). Quantification of the urinary metabolites of α −tocopherol and γ −tocopherol in normal European subjects. Free Radic Biol Med 27 (Suppl 1):S38.
   Google Scholar
• S A Pope, P T Clayton, and D P Muller. (2000). A new method for the analysis of urinary vitamin E metabolites and the tentative identification of a novel group of compounds. Arch Biochem Biophys 381:8–15.
   PubMed Web of Science ®Google Scholar
• R S Parker, T J Sontag, and J E Swanson. (2000). Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun 277:531–534.
   PubMed Web of Science ®Google Scholar
• J E Swanson, R N Ben, G W Burton, and R S Parker. (1999). Urinary excretion of 2,7, 8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of γ-tocopherol in humans. J Lipid Res 40:665–671.
   PubMed Web of Science ®Google Scholar
• J G Bieri, and R P Evarts. (1974). Vitamin E activity of γ-tocopherol in the rat, chick and hamster. J Nutr 104:850–857.
   PubMed Web of Science ®Google Scholar
• M Ohrvall, G Sundlof, and B Vessby. (1996). γ, but not α, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 239:111–117.
   PubMed Web of Science ®Google Scholar
• A Kontush, T Spranger, A Reich, K Baum, and U Beisiegel. (1999). Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and γ-tocopherol. Atherosclerosis 144:117–122.
   PubMed Web of Science ®Google Scholar
• R Cooney, A Franke, P Harwood, V Hatch-Pigott, L Custer, and L Mordan. (1993). γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc Natl Acad Sci USA 90:1771–1778.
   PubMed Web of Science ®Google Scholar
• S Christen, A A Woodall, M K Shigenaga, P T Southwell-Keely, M W Duncan, and B N Ames. (1997). γ-Tocopherol traps mutagenic electrophiles such as NO(X) and complements α-tocopherol: physiological implications. Proc Natl Acad Sci USA 94:3217–3222.
   PubMed Web of Science ®Google Scholar
• S S Marla, J Lee, and J T Groves. (1997). Peroxynitrite rapidly permeates phospholipid membranes. Proc Natl Acad Sci USA 94:14243–14248.
   PubMed Web of Science ®Google Scholar
• L W Morton, N C Ward, K D Croft, and I B Puddey. (2002). Evidence for the nitration of γ-tocopherol in vivo: 5-nitro-γ-tocopherol is elevated in the plasma of subjects with coronary heart disease. Biochem J 18:625–628.
   Google Scholar
• W J Wechter, D Kantoci, E D MurrayJr, D C D'Amico, M E Jung, and W H Wang. (1996). A new endogenous natriuretic factor: LLU-alpha. Proc Natl Acad Sci USA 93:6002–6007.
   PubMed Web of Science ®Google Scholar
• Q Jiang, I Elson-Schwab, C Courtemanche, and B N Ames. (2000). γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 97:11494–11499.
   PubMed Web of Science ®Google Scholar
• M K Horwitt, C C Harvey, G D Duncan, and W C Wilson. (1956). Effects of limited tocopherol intake in man with relationships to erythrocyte hemolysis and lipid oxidations. Am J Clin Nutr 4:408–419.
   PubMed Web of Science ®Google Scholar
• M K Horwitt, B Century, and A A Zeman. (1963). Erythrocyte survival time and reticulocyte levels after tocopherol depletion in man. Am J Clin Nutr 12:99–106.
   PubMedGoogle Scholar
• E Simon, J L Paul, T Soni, A Simon, and N Moatti. (1997). Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 43:285–289.
   PubMed Web of Science ®Google Scholar
• M G Traber, J C Lane, N R Lagmay, and H J Kayden. (1992). Studies on the transfer of tocopherol between lipoproteins. Lipids 27:657–663.
   PubMed Web of Science ®Google Scholar
• E Simon, J L Paul, V Atger, A Simon, and N Moatti. (2000). Study of vitamin E net mass transfer between α-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men. Free Radic Biol Med 28:815–823.
   Google Scholar
• E Simon, J Gariepy, A Cogny, N Moatti, A Simon, and J L Paul. (2001). Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 159:193–200.
   Google Scholar
• J Lehmann. (1981). Comparative sensitivities of tocopherol levels of platelets, red blood cells and plasma for estimating vitamin E nutritional status in the rat. Am J Clin Nutr 34:2104–2110.
   PubMed Web of Science ®Google Scholar
• G T Vatassery, A M Krezowski, and J H Eckfeldt. (1983). Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutr 37:1020–1024.
   PubMed Web of Science ®Google Scholar
• A Nordoy, and E Strom. (1975). Tocopherol in human platelets. J Lipid Res 16:386–391.
   PubMed Web of Science ®Google Scholar
• J Lehmann, D D Rao, J J Canary, and J T Judd. (1988). Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes, and red blood cells. Am J Clin Nutr 47:470–474.
   PubMed Web of Science ®Google Scholar
• M N Diaz, B Frei, J A Vita, and J F KeaneyJr. (1997). Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408–416.
   PubMed Web of Science ®Google Scholar
• F Krotz, H Y Sohn, and U Pohl. (2004). Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 24:1988–1996.
   PubMed Web of Science ®Google Scholar
• J E Freedman, and J F KeaneyJr. (2001). Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 131 (2 Suppl):374S–377S.
   Google Scholar
• P Patrignani, M R Panara, S Tacconelli, F Seta, T Bucciarelli, G Ciabattoni, P Alessandrini, A Mezzetti, G Santini, M G Sciulli, F Cipollone, G Davi, P Gallina, G B Bon, and C Patrono. (2000). Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 102:539–545.
   PubMed Web of Science ®Google Scholar
• N H Dereska, E C McLemore, D J Tessier, D S Bash, and C M Brophy. (2006). Short-term, moderate dosage vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals. J Surg Res 132:121–129.
   Google Scholar
• C Colette, N Pares-Herbute, L H Monnier, and E Cartry. (1988). Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E. Am J Clin Nutr 47:256–261.
   Google Scholar
• L Mabile, K R Bruckdorfer, and C Rice-Evans. (1999). Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 147:177–185.
   PubMedGoogle Scholar
• T Saldeen, D Li, and J L Mehta. (1999). Differential effects of α- and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 34:1208–1215.
   PubMed Web of Science ®Google Scholar
• M Liu, A Wallmon, C Olsson-Mortlock, R Wallin, and T Saldeen. (2003). Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 77:700–706.
   PubMed Web of Science ®Google Scholar
• A C Chan, K Tran, T Raynor, P R Ganz, and C K Chow. (1991). Regeneration of vitamin E in human platelets. J Biol Chem 266:17290–17295.
   PubMed Web of Science ®Google Scholar
• R M Salonen, K Nyyssonen, J Kaikkonen, E Porkkala-Sarataho, S Voutilainen, T H Rissanen, T P Tuomainen, V P Valkonen, U Ristonmaa, H M Lakka, M Vanharanta, J T Salonen, and H E Poulsen. (2003). Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study. Circulation 107:947–953.
   PubMed Web of Science ®Google Scholar
• V Sanguigni, P Pignatelli, L Lenti, D Ferro, A Bellia, R Carnevale, M Tesauro, R Sorge, R Lauro, and F Violi. (2005). Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 111:412–419.
   PubMed Web of Science ®Google Scholar
• M W Clarke, N C Ward, J H Wu, J M Hodgson, I B Puddey, and K D Croft. (2006). Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am J Clin Nutr 83:95–102.
   PubMed Web of Science ®Google Scholar
• M K Horwitt, C C Harvey, C H DahmJr, and M T Searcy. (1972). Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 203:223–236.
   PubMed Web of Science ®Google Scholar
• D I Thurnham, J A Davies, B J Crump, R D Situnayake, and M Davis. (1986). The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23:514–520.
   PubMed Web of Science ®Google Scholar
• D Steinberg. (1992). Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5–6, 1991, Bethesda, Maryland. Circulation 85:2337–2344.
   PubMed Web of Science ®Google Scholar
• D M Colquhoun. (2001). Nutraceuticals: vitamins and other nutrients in coronary heart disease. Curr Opin Lipidol 12:639–646.
   PubMed Web of Science ®Google Scholar
• M de Lorgeril, P Salen, J L Martin, I Monjaud, J Delaye, and N Mamelle. (1999). Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779–785.
   PubMed Web of Science ®Google Scholar
• (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354:447–455. [No authors listed]
   PubMed Web of Science ®Google Scholar
• S Yusuf, G Dagenais, J Pogue, J Bosch, and P Sleight. (2000). Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154–160.
   PubMed Web of Science ®Google Scholar
• M Boaz, S Smetana, T Weinstein, Z Matas, U Gafter, A Iaina, A Knecht, Y Weissgarten, D Brunner, M Fainaru, and M S Green. (2000). Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213–1218.
   PubMed Web of Science ®Google Scholar
• P Jackson, C M Loughrey, J H Lightbody, P T McNamee, and I S Young. (1995). Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41:1135–1138.
   PubMed Web of Science ®Google Scholar
• P V Srinivasa Rao, K V Dakshinamurty, K S Saibaba, R B Sheela, G Venkataramana, V Sreekrishna, J G Ambekar, and L Jayaseelan. (2001). Oxidative stress in haemodialysis: immediate changes caused by passage of blood through the dialyser. Ann Clin Biochem 38:401–405.
   Google Scholar
• A Gazis, and A Fogarty. (2001). Vitamin E supplementation (correspondence). Lancet 357:631–632.
   Google Scholar
• S L Nuttall, M J Kendall, J N Townend, and D C Wheeler. (2001). Vitamin E supplementation (correspondence). Lancet 357:631.
   Google Scholar
• N G Stephens, A Parsons, P M Schofield, F Kelly, K Cheeseman, and M J Mitchinson. (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786.
   PubMed Web of Science ®Google Scholar
• J T Salonen, K Nyyssonen, R Salonen, H M Lakka, J Kaikkonen, E Porkkala-Sarataho, S Voutilainen, T A Lakka, T Rissanen, L Leskinen, T P Tuomainen, V P Valkonen, U Ristonmaa, and H E Poulsen. (2000). Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248:377–386.
   PubMed Web of Science ®Google Scholar
• R Collins, J Armitage, S Parish, P Sleight, and R Peto. (2002). MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23–33.
   PubMed Web of Science ®Google Scholar
• B G Brown, X Q Zhao, A Chait, L D Fisher, M C Cheung, J S Morse, A A Dowdy, E K Marino, E L Bolson, P Alaupovic, J Frohlich, and J J Albers. (2001). Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592.
   PubMed Web of Science ®Google Scholar
• G Bjelakovic, D Nikolova, L L Gluud, R G Simonetti, and C Gluud. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842–857.
   PubMed Web of Science ®Google Scholar
• V A Holmes, and D R McCance. (2005). Could antioxidant supplementation prevent pre-eclampsia?. Proc Nutr Soc 64:491–501.
   PubMed Web of Science ®Google Scholar
• L Poston, A L Briley, P T Seed, F J Kelly, and A H Shennan. (2006). Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367:1145–1154.
   PubMed Web of Science ®Google Scholar
• A R Rumbold, C A Crowther, R R Haslam, G A Dekker, J S Robinson, and ACTS Study Group. (2006). Vitamins C, E and the risks of preeclampsia and perinatal complications. N Engl J Med 354:1796–1806.
   PubMed Web of Science ®Google Scholar
• N C Ward, J H Wu, M W Clarke, I B Puddey, V Burke, K D Croft, and J M Hodgson. (2007). The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25:227–234.
   PubMed Web of Science ®Google Scholar
• G R Wilkinson. (2005). Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221.
   PubMed Web of Science ®Google Scholar
• J Lazarou, B H Pomeranz, and P N Corey. (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205.
   PubMed Web of Science ®Google Scholar
• M M Cotreau, L L von Moltke, and D J Greenblatt. (2005). The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet 44:33–60.
   PubMed Web of Science ®Google Scholar
• K E Thummel, and G R Wilkinson. (1998). In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 38:389–430.
   PubMed Web of Science ®Google Scholar
• L B Moore, B Goodwin, S A Jones, G B Wisely, C J Serabjit-Singh, T M Willson, J L Collins, and S A Kliewer. (2000). St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500–7502.
   PubMed Web of Science ®Google Scholar
• J S Markowitz, J L Donovan, C L DeVane, R M Taylor, Y Ruan, J S Wang, and K D Chavin. (2003). Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290:1500–1504.
   PubMed Web of Science ®Google Scholar
• R Brigelius-Flohe. (2005). Induction of drug metabolizing enzymes by vitamin E. J Plant Physiol 162:797–802.
   PubMed Web of Science ®Google Scholar
• D Kluth, N Landes, P Pfluger, K Muller-Schmehl, K Weiss, C Bumke-Vogt, M Ristow, and R Brigelius-Flohe. (2005). Modulation of Cyp3a11 mRNA expression by alpha-tocopherol but not gamma-tocotrienol in mice. Free Radic Biol Med 38:507–514.
   PubMed Web of Science ®Google Scholar
• M G Traber, L K Siddens, S W Leonard, B Schock, K Gohil, S K Krueger, C E Cross, and D E Williams. (2005). Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets. Free Radic Biol Med 38:773–785.
   PubMed Web of Science ®Google Scholar
• N Landes, P Pfluger, D Kluth, M Birringer, R Ruhl, G F Bol, H Glatt, and R Brigelius-Flohe. (2003). Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 65:269–273.
   PubMed Web of Science ®Google Scholar
• D J Mustacich, S W Leonard, M W Devereaux, R J Sokol, and M G Traber. (2006). alpha-Tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic Biol Med 41:1069–1078.
   PubMed Web of Science ®Google Scholar
• D J Mustacich, A T Vo, V D Elias, K Payne, L Sullivan, S W Leonard, and M G Traber. (2007). Regulatory mechanisms to control tissue alpha-tocopherol. Free Radic Biol Med 43:610–618.
   Google Scholar
• K D Lake, K D Aaronson, L E Gorman, F D Pagani, and T M Koelling. (2005). Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients. J Heart Lung Transplant 24:990–994.
   PubMed Web of Science ®Google Scholar
• A P de Vries, L H Oterdoom, R O Gans, and S J Bakker. (2006). Supplementation with anti-oxidants Vitamin C and E decreases cyclosporine A trough-levels in renal transplant recipients. Nephrol Dial Transplant 21:231–232.
   Google Scholar
• M L Blackhall, R G Fassett, J E Sharman, D P Geraghty, and J S Coombes. (2005). Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients. Nephrol Dial Transplant 20:1970–1975.
   Google Scholar
• Y F Hu, W Qiu, Z Q Liu, L J Zhu, Z Q Liu, J H Tu, D Wang, Z Li, J He, G P Zhong, G Zhou, and H H Zhou. (2006). Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clin Exp Pharmacol Physiol 33:1093–1098.
   PubMedGoogle Scholar
• E L LeCluyse. (2001). Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem Biol Interact 134:283–289.
   PubMed Web of Science ®Google Scholar
• Y Zhai, H V Pai, J Zhou, J A Amico, R R Vollmer, and W Xie. (2007). Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 21:138–147.
   PubMed Web of Science ®Google Scholar
• O P Heinonen. (1994). The effect of vitamin E beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029–1035.
   PubMed Web of Science ®Google Scholar
• T J Hartman, J F Dorgan, J Virtamo, J A Tangrea, P R Taylor, and D Albanes. (1999). Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cancer 35:10–15.
   PubMed Web of Science ®Google Scholar
• S J Weinstein, M E Wright, K A Lawson, K Snyder, S Mannisto, P R Taylor, J Virtamo, and D Albanes. (2007). Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16:1253–1259.
   PubMed Web of Science ®Google Scholar
• D P Vivekananthan, M S Penn, S K Sapp, A Hsu, and E J Topol. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361:2017–2023.
   PubMed Web of Science ®Google Scholar
• J N Hathcock, A Azzi, J Blumberg, T Bray, A Dickinson, B Frei, I Jialal, C S Johnston, F J Kelly, K Kraemer, L Packer, S Parthasarathy, H Sies, and M G Traber. (2005). Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 81:736–745.
   PubMed Web of Science ®Google Scholar
• J Chen, J He, L Hamm, V Batuman, and P K Whelton. (2002). Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 40:810–816.
   PubMed Web of Science ®Google Scholar
• M E Wright, K A Lawson, S J Weinstein, P Pietinen, P R Taylor, J Virtamo, and D Albanes. (2006). Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 84:1200–1207.
   PubMed Web of Science ®Google Scholar
• X Gao, P E Wilde, A H Lichtenstein, O I Bermudez, and K L Tucker. (2006). The maximal amount of dietary alpha-tocopherol intake in U. S. adults (NHANES 2001-2002). J Nutr 136:1021–1026.
   PubMedGoogle Scholar
• E S Ford, U A Ajani, and A H Mokdad. (2005). Brief communication: the prevalence of high intake of vitamin E from the use of supplements among U. S. adults. Ann Intern Med 143:116–120.
   PubMed Web of Science ®Google Scholar
• G W Burton, M G Traber, R V Acuff, D N Walters, H Kayden, L Hughes, and K U Ingold. (1998). Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr 67:669–684.
   PubMed Web of Science ®Google Scholar
• P Mardones, P Strobel, S Miranda, F Leighton, V Quinones, L Amigo, J Rozowski, M Krieger, and A Rigotti. (2002). Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J Nutr 132:443–449.
   PubMed Web of Science ®Google Scholar